Your Business in Court -- 2005
John B. Reiss, a Partner in the Business Department and Co-Chair of the Health Law Practice Group, Partner Mark C. Levy in the Litigation Department, and Allison B. Newhart, an Associate in the Litigation Department, all resident in the Philadelphia office wrote this article for Update Magazine.
Mr. Reiss, Mr. Levy, and Ms. Newhart examine the high case rate of pharmaceutical and medical device companies. They discuss certain federal agencies, including The Federal Trade Commission (FTC) and the Securities Exchange Commission (SEC), and apply them to several cases.
The authors conclude that in order for marketing programs to maintain a reasonable scheme, compliance plans should be incorporated in a company’s activities to remain in accordance with government regulations.
To read the article, published with permission from FDLI, please click the link below.